BR100 Decreased By (-0.09%)
BR30 Decreased By (-0.08%)
KSE100 Decreased By (-0.06%)
KSE30 Decreased By (-0.13%)
AGHA 7.72 Decreased By ▼ -0.09 (-1.15%)
BECO 5.18 Decreased By ▼ -0.03 (-0.58%)
BML 57.50 No Change ▼ 0.00 (0%)
BOP 33.90 Decreased By ▼ -0.13 (-0.38%)
CNERGY 9.97 Increased By ▲ 0.01 (0.1%)
CSIL 5.35 Increased By ▲ 0.04 (0.75%)
FCCL 54.40 Decreased By ▼ -0.30 (-0.55%)
FFL 16.70 Increased By ▲ 0.01 (0.06%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 7.35 Decreased By ▼ -0.05 (-0.68%)
KOSM 5.71 Decreased By ▼ -0.06 (-1.04%)
LOTCHEM 29.16 Decreased By ▼ -0.16 (-0.55%)
MLCF 93.45 Decreased By ▼ -0.91 (-0.96%)
NBP 202.70 Decreased By ▼ -0.35 (-0.17%)
NCPL 56.80 Decreased By ▼ -0.20 (-0.35%)
NPL 67.61 Decreased By ▼ -0.09 (-0.13%)
OGDC 316.77 Increased By ▲ 0.93 (0.29%)
PACE 10.68 Increased By ▲ 0.04 (0.38%)
PAEL 43.15 Decreased By ▼ -0.05 (-0.12%)
PIBTL 16.68 Decreased By ▼ -0.06 (-0.36%)
PPL 218.50 Decreased By ▼ -1.28 (-0.58%)
PRL 49.80 Increased By ▲ 0.61 (1.24%)
PTC 70.95 Increased By ▲ 0.42 (0.6%)
SSGC 27.98 Decreased By ▼ -0.27 (-0.96%)
TBL 9.83 Decreased By ▼ -0.03 (-0.3%)
TELE 8.75 Decreased By ▼ -0.04 (-0.46%)
TPL 18.14 Decreased By ▼ -0.10 (-0.55%)
TPLP 13.54 Increased By ▲ 0.27 (2.03%)
TREET 22.75 Increased By ▲ 0.03 (0.13%)
TRG 60.50 Increased By ▲ 0.36 (0.6%)
Business & Finance

Germany expects 40.2mn doses of Biontech COVID vaccine in Q2

  • The document, which was prepared for a virtual meeting of Chancellor Angela Merkel with the 16 state premiers and representatives of pharmaceutical companies and the European Union later on Monday.
Published Updated
By

BERLIN: The German government expects 40.2 million doses of Biontech/Pfizer's COVID-19 vaccine in the second quarter, a government document seen by Reuters on Monday showed.

The document, which was prepared for a virtual meeting of Chancellor Angela Merkel with the 16 state premiers and representatives of pharmaceutical companies and the European Union later on Monday, also said that the government sees potential delivery and production risks.

Comments

Comments are closed for this article.